`Date filed: June 21, 2016
`
`Filed On Behalf Of:
`
`Alkermes Pharma Ireland Limited and
`Alkermes Controlled Therapeutics, Inc.
`
`By:
`
`Scott K. Reed
`sreed@fchs.com
`212-218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA(USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL CO., LTD., and NANJING LUYE
`PHARMACEUTICAL CO., LTD.,
`Petitioners,
`v.
`ALKERMES PHARMA IRELAND LTD,
`Patent Owner.
`____________
`
`Case IPR2016-01096
`Patent 6,667,061
`____________
`
`PATENT OWNERS’ MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8(a)(2)
`
`
`
`REAL PARTY-IN-INTEREST PURSUANT TO 37 C.F.R. § 42.8(b)(1)
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(a)(2), the undersigned
`
`states that Alkermes Pharma Ireland Limited and Alkermes Controlled
`
`Therapeutics, Inc. (hereinafter, collectively “Patent Owners”) jointly own U.S.
`
`Patent No. 6,667,061 (“the ’061 Patent”). Patent Owners and the parent company
`
`of Alkermes Controlled Therapeutics, Inc., Alkermes, Inc., are the real parties-in-
`
`interest.
`
`Janssen Pharmaceuticals, Inc. and Amylin Pharmaceuticals, LLC also have
`
`an interest in this matter by virtue of holding exclusive licenses to the ’061 Patent.
`
`RELATED MATTERS PURSUANT TO 37 C.F.R. § 42.8(b)(2)
`
`IPR2016-01095, filed on the same day as the instant IPR by the same
`
`Petitioners also concerns the ’061 Patent.
`
`IDENTIFICATION OF LEAD AND BACK-UP COUNSEL
`PURSUANT TO 37 C.F.R. §§ 42.8(b)(3) and 42.10
`
`Pursuant to 37 C.F.R. §§ 42.8(b)(3) and 42.10, Patent Owners designate as
`
`lead counsel:
`
`Scott K. Reed (Reg. No. 32,433)
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`
`1
`
`
`
`Facsimile: (212) 218-2200
`sreed@fchs.com
`
`Pursuant to 37 C.F.R. §§ 42.8(b)(3) and 42.10, Patent Owners designate as
`
`back-up counsel:
`
`Justin J. Oliver (Reg. No. 44,986)
`Fitzpatrick, Cella, Harper & Scinto
`975 F Street, NW
`Washington, DC 20004-1462
`Telephone: (202) 721-5423
`Facsimile: (202) 530-1055
`joliver@fchs.com
`
`A power of attorney from Patent Owners is being submitted with this Notice.
`
`SERVICE INFORMATION PURSUANT TO 37 C.F.R. § 42.8(b)(4)
`
`Patent Owners may be served electronically using the following e-mail
`
`address:
`
`AlkermesIPR@fchs.com
`
`Respectfully submitted,
`
`Dated: June 21, 2016
`
`/s / Scott K. Reed
`Scott K. Reed
`Registration No. 32,433
`Lead Counsel for Patent Owners
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`
`2
`
`
`
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that a copy of the Patent Owners’ Mandatory Notices Under 37
`
`C.F.R. § 42.8(a)(2) was served on June 21, 2016 by causing it to be sent by email
`
`to counsel for Petitioners at the following email address, who consented to
`
`electronic service at these addresses in the Petition:
`
`wmentlik.ipr@lernerdavid.com
`
`pkochanski@lernerdavid.com
`
`tvanbuskirk@lernerdavid.com
`
`nvaleyko@lernerdavid.com
`
`Dated: June 21, 2016
`
`/s/ Scott K. Reed
`Scott K. Reed
`Registration No. 32,433
`Lead Counsel for Patent Owners
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`FCHS_WS 12564733v1.doc
`
`4